Physician profile
Kermit E White
NPI 1528045903
$253.77
in general payments reported to CMS, 2019-2025
7 companies · $21.98 in 2025
The $21.98 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.32 · 2023: $37.53 · 2024: $177 · 2025: $21.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $82.54 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $48.13 | 2024 | Zepbound, Mounjaro, Jardiance |
| Shield Therapeutics INC | $36.40 | 2022-2023 | Accrufer |
| Abiomed | $28.38 | 2024 | Impella |
| Vanda Pharmaceuticals INC. | $21.98 | 2025 | Fanapt |
| Pfizer INC. | $18.45 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $17.89 | 2024 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kermit White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.